1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Taiwan Pharmaceuticals and Healthcare Report Q3 2016

Taiwan Pharmaceuticals and Healthcare Report Q3 2016

  • July 2016
  • -
  • Business Monitor International
  • -
  • 88 pages

Includes 3 FREE quarterly updates

BMI View: Cross-strait relations will be an important factor influencing the prospects of Taiwan'spharmaceutical industry. The country's medicine exports to China have grown substantially and nowaccount for 14% of the total value, ahead of its exports to Japan and South Korea. Growth prospects inChina are also more promising as the domestic market continues to be hampered by price controls. WhilePresident Tsai Ing-wen's focus on the pharmaceutical industry can prove positive, there will also beuncertainties involved as she has yet to articulate her China policy.Headline Expenditure Projections

- Pharmaceuticals: TWD174bn (USD5.5bn) in 2015 to TWD181bn (USD5.6bn) in 2016; + 3.9% in localcurrency and 1.6% in US dollar terms.

- Healthcare: TWD1,046bn (USD32bn) in 2015 to TWD1,090bn (USD33bn) by 2016; + 4.2% in localcurrency terms and +1.9% in US dollar terms.

Table Of Contents

Taiwan Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Taiwan 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Taiwan 2012-2020) 13
Healthcare Market Forecast 14
Table: Copayments Levels (TWD) 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Taiwan 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Taiwan 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Taiwan 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Taiwan 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Taiwan 2012-2020) 23
Generic Drug Market Forecast 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Taiwan 2012-2020) 25
OTC Medicine Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Taiwan 2012-2020) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Taiwan 2014-2020) 29
Table: Pharmaceutical Trade Data And Forecasts local currency (Taiwan 2014-2020) 30
Industry Risk/Reward Index 31
Asia Pacific Risk/Reward Index - Q3 2016 31
Taiwan Risk/Reward Index 37
Rewards 37
Risks 37
Regulatory Review 39
Table: Medicine Categories In Taiwan 40
Table: Examples Of Controlled Drugs In Taiwan 40
Intellectual Property Issues 41
Pricing and Reimbursement Regime 42
Table: Price Adjustments Enacted 42
Market Overview 44
Market Overview 44
Healthcare Sector 44
Table: NHI Premium Contribution Ratios 45
Table: Healthcare Resources (Taiwan 2010-2015) 46
Table: Healthcare Personnel (Taiwan 2010-2015) 46
Table: Healthcare Activity (Taiwan 2010-2015) 47
Clinical Trials 47
Epidemiology 49
Competitive Landscape 52
Research-Based Industry 52
Table: Corporate Member Companies Of IRPMA 52
Table: Multinational Market Activity 53
Generic Drugmakers 54
Table: Members of Taiwan Generic Pharmaceutical Association (As of June 2016) 55
Pharmaceutical Distribution 56
Pharmaceutical Retail Sector 56
Company Profile 58
GlaxoSmithKline (GSK) 58
Merck and Co 61
Novartis 63
Pfizer 66
ScinoPharm Taiwan 68
TaiGen 72
Yung Shin Pharmaceutical (YSP) 75
Demographic Forecast 77
Table: Population Headline Indicators (Taiwan 1990-2025) 78
Table: Key Population Ratios (Taiwan 1990-2025) 78
Table: Urban/Rural Population and Life Expectancy (Taiwan 1990-2025) 79
Table: Population By Age Group (Taiwan 1990-2025) 79
Table: Population By Age Group % (Taiwan 1990-2025) 80
Glossary 82
Methodology 84
Pharmaceutical Expenditure Forecast Model 84
Healthcare Expenditure Forecast Model 84
Notes On Methodology 85
Risk/Reward Index Methodology 86
Index Overview 87
Table: Pharmaceutical Risk/Reward Index Indicators 87
Indicator Weightings 88

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.